With the development, production and distribution of pharmaceutical specialties, we have been contributing to people’s health for more than 30 years. Our strengths include the development and manufacture of sterile liquid dosage forms and small molecule active pharmaceutical ingredients. For our own needs and as CDMO for third parties.
In Austria, we develop, produce and distribute some of the most established generic imaging agents under the Sanochemia brand. Our products help physicians make efficient therapeutic decisions for patients.
With contract manufacturing of sterile and low-bioburden liquids as well as APIs, we offer in-depth expertise in the field of drug product and API production. As a full-service provider, we also support with GMP services.
The multicentric prospective PROSTAPROGRESS study on Ferumoxtran confirmed to meet also secondary endpoints. Post-hoc analysis showed elevated sensitivity and specificity data for metastatic lymph node lesions at levels surpassing the levels of current technologies.
Read moreIn line with its focus to redefine medical imaging with cell-specific and gadolinium-free MRI contrast agents, Sanochemia Pharmazeutika is pleased to announce the appointment of Faizal Mansor as Head of Product Strategy.
Read moreNeufeld, Austria, February 25th, 2025 – Sanochemia Pharmazeutika today announced positive headline results of the…
Read more
